Loading...

Straumann Holding AG

STMN.SWSIX
Healthcare
Medical - Instruments & Supplies
CHF104.20
CHF-3.65(-3.38%)

Straumann Holding AG (STMN.SW) Stock Overview

Explore Straumann Holding AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap16.6B
P/E Ratio42.97
EPS (TTM)$2.87
ROE0.19%
Fundamental Analysis

AI Price Forecasts

1 Week$103.38
1 Month$103.09
3 Months$91.86
1 Year Target$126.32

STMN.SW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Straumann Holding AG (STMN.SW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 46.99, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $126.32.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 42.97 and a market capitalization of 16.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Technical Indicators

46.99RSI (14)
0.05MACD
10.48ADX
Revenue Growth
3.82%
3.82%
Profit Growth
CHF2.42
57.81%
EPS Growth
CHF2.42
58.44%
Operating Margin
23.66%
46.24%
ROE
19.29%
57.81%
Dividend Yield
0.00%
6.26%
Analyst Recommendations data is not available for STMN.SWAnalyst Recommendations details for STMN.SW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company offers dental implant systems for tissue and bone level; titanium, titanium alloy, ceramic, and mini dental implant systems; and guided and non-guided surgical instruments, as well as implant-borne prosthetics. It provides ceramic healing and screw retained abutments; intraoral scanning solutions; 3D printers; milling machines; and prevention products. In addition, it offers biomaterials, bone substitutes, membranes, biologics, and soft tissue management and oral healing products; digital solutions for dental labs, dentists, and centralized milling centers, as well as materials, third party systems, and guided surgery; surgical instruments comprising surgical and modular cassettes, guided instruments, implant maintenance products, bone block fixation sets, bonerings, titanium pin sets, and other cassettes; and edentulous, pro arch fixed, prosthetic, and mini implant solutions for edentulous patients. Further, it provides esthetic restorations that include ceramic implant monotypes, ceramic implants, abutments, biologics, and other solutions; and Emdogain for wound healing. Further, it offers systems Clear Correct aligners; and training and education services to its customers. The company provides its products to general dentists, specialists, and dental technicians and laboratories, as well as corporate customers, such as distributors, hospitals, universities, and dental service organizations in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.

CEO

Guillaume Daniellot

Employees

11,342

Headquarters

Peter Merian-Weg 12, Basel

Founded

1998

Frequently Asked Questions

;